Cargando…
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
Recurrent glioma treatment is challenging due to molecular heterogeneity and treatment resistance commonly observed in these tumors. Researchers are actively pursuing new therapeutic strategies. Oncolytic viruses have emerged as a promising option. Oncolytic viruses selectively replicate within tumo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652401/ https://www.ncbi.nlm.nih.gov/pubmed/38022620 http://dx.doi.org/10.3389/fimmu.2023.1285113 |